Innovative

Products

Harness the innate power of the human body

CellGenuity develops biologics designed to be used as a therapeutic agent.  Formulated with our patented PūrAMP Process™, our products are used in a wide range of surgical and non-surgical applications.

AmnioAMP-MP™

Allograft Patch

AmnioAMP-MP™ is a membrane allograft that may be used as a therapeutic active barrier agent in numerous clinical applications. The membrane forms a protective covering over the wound to preserve tissue structure and biologic integrity.  AmnioAMP-MP™ created with our proprietary PūrAMP Process™, offers mechanical protection and retains nutrient growth factors that are essential for signaling¹².  The product undergoes active preservation of the extracellular matrix (ECM), regulatory proteins, and removal of blood contaminants via a proprietary PūrAMP Process™.  AmnioAMP-MP™ is HCT/P compliant under section 361 of the Public Health Service Act according to 21 CFR Part 1271.10.  They are regulated as human cell product-for homologous use only.

AmnioAllograft

Purified Amnion Fluid

AmnioAllograft™ is a non structural minimally manipulated liquid allograft derived from amniotic fluid that functions to cushion and protect the fetus in utero.  Amniotic fluid contains vital components, such as nutrients and infection fighting antibodies.  AmnioAllograft™ functions in the same homologous way of providing protection by acting as a shock absorber and temperature control through insulation.  Our PūrAMP Process™ never alters the native, regenerative properties of the allograft tissue; the integrity and characteristics are always maintained. AmnioAllograft™ is HCT/P compliant under section 361 of the Public Health Service Act according to 21 CFR Part 1271.10. They are regulated as human cell product-for homologous use only.

AmnioAMP-WJ™

Wharton’s Jelly Allograft

AmnioAMP-WJ™ contains isolated Wharton’s Jelly derived from the umbilical cord that provides cushioning and support to the umbilical vein and arteries.  Wharton’s Jelly does not exhibit an immune reaction or rejection, considered “immune privileged”.  Our proprietary PūrAMP Process™ does not alter the original tissue’s function as a Wharton’s Jelly connective tissue, providing physical support and cushioning.  AmnioAMP-WJ™ is regulated as human cell, tissue or cellular-tissue based product (HCT/P) 21 CFR Part 1271.10 and 361 of the Public Health Service Act.  They are regulated as human cell product-for homologous use only.

PHYSICIANS?

Join the other physicians that are finding the value in the “DAY-ONE” Process and products developed by CellGenuity. Click here to get connected with our team.

Product
Cell Genuity